DaVita Inc. (NYSE:DVA) Shares Purchased by Jones Financial Companies Lllp

Jones Financial Companies Lllp grew its position in shares of DaVita Inc. (NYSE:DVA) by 28.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 517 shares of the company’s stock after acquiring an additional 115 shares during the quarter. Jones Financial Companies Lllp’s holdings in DaVita were worth $77,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of DVA. Quarry LP acquired a new position in shares of DaVita during the third quarter worth approximately $60,000. Venturi Wealth Management LLC lifted its stake in shares of DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after acquiring an additional 152 shares during the period. Versant Capital Management Inc boosted its holdings in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares in the last quarter. Blue Trust Inc. increased its stake in shares of DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after acquiring an additional 131 shares during the period. Finally, Wingate Wealth Advisors Inc. acquired a new position in shares of DaVita during the 4th quarter valued at $82,000. Institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on DVA. Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Barclays lifted their target price on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price objective on DaVita in a report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $166.33.

DaVita Trading Up 1.7 %

DaVita stock opened at $143.56 on Monday. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The stock has a market cap of $11.48 billion, a P/E ratio of 13.37, a P/E/G ratio of 1.07 and a beta of 0.99. The company’s fifty day simple moving average is $158.92 and its 200-day simple moving average is $157.65.

DaVita (NYSE:DVA) last issued its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, sell-side analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.